Literature DB >> 16602631

Radiotherapy-induced lymphocytopenia: changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasms.

P Lissoni1, S Meregalli, E Bonetto, M Mancuso, F Brivio, M Colciago, G Gardani.   

Abstract

Lymphocytopenia is one of the most negative biological prognostic factors in cancer patients. Lymphocytopenia may depend on tumor progression, or on various anticancer therapies. In particular, radiotherapy (RT) may induce direct lymphocyte damage. The present study was carried out to evaluate the influence of pelvic irradiation on lymphocyte number and lymphocyte subpopulations in patients with gynecologic tumors. The study included 40 patients affected by locally limited or advanced uterine tumors, who underwent pelvic irradiation for a total dose of 50.4 Gy. RT induced a significant decline in total lymphocyte number, with values lower than 500/mm3 in 29/40 (73%) patients and with a mean decrease of 71 +/- 4%. In the same way, T lymphocyte, CD4, CD8 and NK cell mean numbers significantly decreased under RT. The decline in NK and CD8 cells was limited to the first 2-3 weeks of irradiation, whereas that involving T lymphocytes and CD4 cells was progressive and persistent until the end of RT. Finally, the decline in total lymphocyte number was significantly greater in patients who had no tumor regression in response to RT. This study confirms that pelvic RT may induce severe lymphocytopenia which could negatively influence the efficacy of RT itself.

Entities:  

Mesh:

Year:  2005        PMID: 16602631

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  17 in total

1.  The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas.

Authors:  Ani Balmanoukian; Xiaobu Ye; Joseph Herman; Daniel Laheru; Stuart A Grossman
Journal:  Cancer Invest       Date:  2012-07-19       Impact factor: 2.176

2.  External beam radiation therapy and abiraterone in men with localized prostate cancer: safety and effect on tissue androgens.

Authors:  Eunpi Cho; Elahe A Mostaghel; Kenneth J Russell; Jay J Liao; Mark A Konodi; Brenda F Kurland; Brett T Marck; Alvin M Matsumoto; Bruce L Dalkin; R Bruce Montgomery
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-03-12       Impact factor: 7.038

3.  Modulation of Peripheral Immune Cell Subpopulations After RapidArc/Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: Findings and Comparison With 3D Conformal/Conventional Fractionation Treatment.

Authors:  Fiorella D'Auria; Teodora Statuto; Luciana Rago; Antonietta Montagna; Giovanni Castaldo; Irene Schirò; Anna Zeccola; Teresa Virgilio; Gabriella Bianchino; Antonio Traficante; Alessandro Sgambato; Vincenzo Fusco; Luciana Valvano; Giovanni Calice
Journal:  Front Oncol       Date:  2022-06-01       Impact factor: 5.738

4.  Lymphopenia and its association with survival in patients with locally advanced cervical cancer.

Authors:  Emily S Wu; Titilope Oduyebo; Lauren P Cobb; Diana Cholakian; Xiangrong Kong; Amanda N Fader; Kimberly L Levinson; Edward J Tanner; Rebecca L Stone; Anna Piotrowski; Stuart Grossman; Kara Long Roche
Journal:  Gynecol Oncol       Date:  2015-11-11       Impact factor: 5.482

5.  Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer.

Authors:  Oyeon Cho; Young-Taek Oh; Mison Chun; O Kyu Noh; Hyun-Woo Lee
Journal:  Tumour Biol       Date:  2015-08-12

6.  Clinical opportunities in combining immunotherapy with radiation therapy.

Authors:  Steven E Finkelstein; Mayer Fishman
Journal:  Front Oncol       Date:  2012-11-26       Impact factor: 6.244

7.  Transient expansion and myofibroblast conversion of adipogenic lineage precursors mediate bone marrow repair after radiation.

Authors:  Leilei Zhong; Lutian Yao; Nicholas Holdreith; Wei Yu; Tao Gui; Zhen Miao; Yehuda Elkaim; Mingyao Li; Yanqing Gong; Maurizio Pacifici; Amit Maity; Theresa M Busch; Kyu Sang Joeng; Keith Cengel; Patrick Seale; Wei Tong; Ling Qin
Journal:  JCI Insight       Date:  2022-04-08

Review 8.  Optimal management of cervical cancer in HIV-positive patients: a systematic review.

Authors:  Atara Ntekim; Oladapo Campbell; Dietrich Rothenbacher
Journal:  Cancer Med       Date:  2015-07-01       Impact factor: 4.452

9.  Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer.

Authors:  D Koeberle; R Burkhard; R von Moos; R Winterhalder; V Hess; F Heitzmann; T Ruhstaller; L Terraciano; J Neuweiler; G Bieri; C Rust; M Toepfer
Journal:  Br J Cancer       Date:  2008-03-18       Impact factor: 7.640

10.  Peripheral lymphocyte subset variation predicts prostate cancer carbon ion radiotherapy outcomes.

Authors:  Zhang-Ru Yang; Ning Zhao; Jin Meng; Ze-Liang Shi; Bing-Xin Li; Xian-Wei Wu; Ping Li; Qing Zhang; Xun-Bin Wei; Shen Fu
Journal:  Oncotarget       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.